Investigation Overview
The announcement of a proposed buyout of Clinical Data, Inc. prompted an investigation on behalf of investors in Clinical Data, Inc. (NASDAQ:CLDA) shares questioning a potential unfairness of the takeover and possible breaches of fiduciary duties by certain Clinical Data officers and directors. The investigation by a law firm concerns possible breaches of fiduciary duties by certain ...
You must register (for free) or login to view the entire investigation.